Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
22.95
+0.42 (1.86%)
Apr 29, 2026, 3:00 PM CST

SHA:605033 Revenue

In the year 2025, Shaanxi Meibang Pharmaceutical Group had annual revenue of 911.95M CNY with 2.98% growth. Shaanxi Meibang Pharmaceutical Group had revenue of 303.07M in the quarter ending December 31, 2025, with 15.34% growth.

Revenue
911.95M
Revenue Growth
+2.98%
P/S Ratio
3.40
Revenue / Employee
913.78K
Employees
998
Market Cap
3.10B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025911.95M26.42M2.98%
Dec 31, 2024885.53M186.50M26.68%
Dec 31, 2023699.03M-207.02M-22.85%
Dec 31, 2022906.05M63.56M7.54%
Dec 31, 2021842.49M273.97M48.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition